project id: TCGA-SKCM; case submitter id: TCGA-D3-A3ML; source center: 23; state: released; a260 a280 ratio: 1.76; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 9.1; age at index: 70; days to birth: -25643; days to death: 422; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Dead; year of birth: 1933; year of death: 2004; age at diagnosis: 25643; ajcc pathologic m: M0; ajcc pathologic n: N2a; ajcc pathologic stage: Stage IIIA; ajcc pathologic t: T3a; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C77.0; last known disease status: not reported; morphology: 8720/3; primary diagnosis: Malignant melanoma, NOS; prior malignancy: yes; prior treatment: Yes; progression or recurrence: not reported; site of resection or biopsy: Lymph nodes of head, face and neck; synchronous malignancy: Not Reported; tissue or organ of origin: Skin, NOS; tumor grade: Not Reported; year of diagnosis: 2003; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 3205; initial weight: 120.0; sample id: 9f0595af-851f-46a6-b643-c76affe79746; sample submitter id: TCGA-D3-A3ML-06A; portion id: d1ebe695-94ec-4ee6-8131-c0b441f6a8da; portion submitter id: TCGA-D3-A3ML-06A-11; slide id: 2fc545da-de1e-4e45-97d9-c35f964df71a; slide submitter id: TCGA-D3-A3ML-06A-01-TSA; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 95.0; section location: TOP;